KEVZARA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Sarilumab.
| Product ID | 0024-5908_01aea597-9923-4257-9aa6-f6a5f33cf627 |
| NDC | 0024-5908 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KEVZARA |
| Generic Name | Sarilumab |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2017-05-22 |
| Marketing Category | BLA / BLA |
| Application Number | BLA761037 |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | SARILUMAB |
| Active Ingredient Strength | 150 mg/1.14mL |
| Pharm Classes | Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-05-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA761037 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-05-22 |
| Marketing Category | BLA |
| Application Number | BLA761037 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-05-22 |
| Ingredient | Strength |
|---|---|
| SARILUMAB | 150 mg/1.14mL |
| SPL SET ID: | 827bc01c-d379-4266-a18c-c7f904b76af3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0024-5908 | KEVZARA | sarilumab |
| 0024-5910 | KEVZARA | sarilumab |
| 0024-5920 | KEVZARA | sarilumab |
| 0024-5922 | KEVZARA | sarilumab |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KEVZARA 87275074 5274968 Live/Registered |
Sanofi Biotechnology 2016-12-20 |
![]() KEVZARA 86394577 4780600 Live/Registered |
SANOFI BIOTECHNOLOGY 2014-09-15 |